The role of miR-26 in tumors and normal tissues (Review)

Gao,Jie; Liu,Qing-Guang

doi:10.3892/ol.2011.413

The role of miR-26 in tumors and normal tissues (Review)

Authors:
- Jie Gao
- Qing-Guang Liu
View Affiliations

Affiliations: Hepatobiliary Surgery Department, the First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: September 5, 2011 https://doi.org/10.3892/ol.2011.413
Pages: 1019-1023

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

miR-26, a functional miRNA, has received much attention from researchers in recent years. miRNAs may play crucial roles in numerous biological processes such as cell proliferation, apoptosis, tumorigenesis at different stages of non-tumor diseases, growth and development of normal tissues, and other biological processes. The expression of miR-26 has been found to be specific to different biological processes. Furthermore, its expression is frequently abnormal in tumors, indicating that miR-26 may play significant roles in tumor formation. Various reports exist regarding miR-26 involvement in non-tumor diseases, as well as the process of growth and development of normal tissues. In this review, we report findings of recent studies on the expression of miR-26 in different types of diseases and the process of growth and development and its predicted target genes in different tissue types. In conclusion, it is useful for researchers to understand the role of miR-26 in different biological processes.

View Figures

View References

1	Liu X, Chen Z, Yu J and Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics. 837514:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
2	Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
3	Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
4	Xiaohui X, Jun L, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature. 434:338–345. 2005.
5	Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI
6	Stefani G and Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008. View Article : Google Scholar : PubMed/NCBI
7	Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
9	Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
10	Chang TC and Mendell TJ: microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 8:215–239. 2007. View Article : Google Scholar : PubMed/NCBI
11	Kloosterman WP and Plasterk RHA: The diverse functions of microRNAs in animal development and disease. Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
12	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
13	Tong AW and Nemunaitis J: Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 15:341–355. 2008. View Article : Google Scholar : PubMed/NCBI
14	Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
15	Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad of Sci U S A. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
16	Muinos-Gimeno M, Montfort M, Bayes M, Estivill X and Espinosa-Parrilla Y: Design and evaluation of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet. 18:218–226. 2010. View Article : Google Scholar : PubMed/NCBI
17	Diederichs S and Haber DA: Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res. 66:6097–6104. 2006. View Article : Google Scholar : PubMed/NCBI
18	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
19	Iorio Marilena V, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065–7070. 2005.PubMed/NCBI
20	Wang G, Zhang H, He H, et al: Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol. 42:95–102. 2009. View Article : Google Scholar : PubMed/NCBI
21	Maillot G, Lacroix-Triki M, Pierredon S, et al: Widespread estrogen-dependent repression of microRNAs in breast tumor cell growth. Cancer Res. 69:8332–8340. 2009. View Article : Google Scholar : PubMed/NCBI
22	Zhang B, Liu XX, He JR, et al: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2010. View Article : Google Scholar : PubMed/NCBI
23	Yu T, Wang XY, Gong RG, et al: The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance- induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res. 28:64–73. 2009.PubMed/NCBI
24	Visone R, Pallante P, Vecchione A, et al: Specific microRNA are downregulated in human thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007. View Article : Google Scholar : PubMed/NCBI
25	Ciarapica R, Russo G, Verginelli F, Donfrancesco A, Rota R and Giordano A: Deregulated expression of miR-26a and EZH2 in rhabdomyosarcoma. Cell Cycle. 8:172–175. 2009. View Article : Google Scholar : PubMed/NCBI
26	Sandrine S, Lars B and Thomas W: Repressing the repressor: a new mode of MYC action in lymphomagenesis. Cell Cycle. 8:556–559. 2009. View Article : Google Scholar : PubMed/NCBI
27	Kota J, Chivukula RR, O’Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
28	Ji J, Shi J, Budhu A, et al: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
29	Huse JT, Brennan C, Hambardzumyan D, et al: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes and Dev. 23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
30	Kim H, Huang W, Jiang X, Pennicooke B, Park PJ and Johnson MD: Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad of Sci USA. 107:2183–2188. 2010. View Article : Google Scholar : PubMed/NCBI
31	Padgett KA, Lan RY, Leung PC, et al: Primary billiary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 32:246–253. 2009. View Article : Google Scholar : PubMed/NCBI
32	Rogler CE, LeVoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster microRNA regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
33	Itoh T, Nozawa Y and Akao Y: MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem. 284:19272–19279. 2009. View Article : Google Scholar : PubMed/NCBI
34	Wong CF and Tellam RL: MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myogenesis. J Biol Chem. 283:9836–9843. 2008. View Article : Google Scholar : PubMed/NCBI